Bank of New York Mellon Corp - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,905
+80.1%
39,9490.0%0.00%
Q2 2023$6,612
-83.0%
39,9490.0%0.00%
Q1 2023$38,990
-6.2%
39,9490.0%0.00%
Q4 2022$41,547
-9.7%
39,9490.0%0.00%
Q3 2022$46,000
-41.8%
39,949
-4.7%
0.00%
Q2 2022$79,000
-34.7%
41,933
+5.0%
0.00%
Q1 2022$121,000
-20.4%
39,949
-0.5%
0.00%
Q4 2021$152,000
-26.9%
40,1440.0%0.00%
Q3 2021$208,000
+173.7%
40,144
+104.1%
0.00%
Q2 2021$76,000
-76.1%
19,666
-84.1%
0.00%
Q1 2021$318,000
+1.3%
123,671
-1.5%
0.00%
Q4 2020$314,000
+14.2%
125,563
-5.7%
0.00%
Q3 2020$275,000
-33.3%
133,120
+0.3%
0.00%
Q2 2020$412,000
+36.0%
132,755
+0.0%
0.00%
Q1 2020$303,000
-37.4%
132,722
-0.9%
0.00%
Q4 2019$484,000
+15.8%
133,862
+9.3%
0.00%
Q3 2019$418,000
-17.9%
122,452
+12.9%
0.00%
Q2 2019$509,000
+32.6%
108,505
-5.4%
0.00%
Q1 2019$384,000
+25.9%
114,6550.0%0.00%
Q4 2018$305,000
-52.2%
114,655
+0.7%
0.00%
Q3 2018$638,000
+15.8%
113,908
+4.9%
0.00%
Q2 2018$551,000
-58.5%
108,599
-44.2%
0.00%
Q1 2018$1,327,000
+126.1%
194,638
+150.7%
0.00%
Q4 2017$587,000
+34.6%
77,645
+2.6%
0.00%
Q3 2017$436,000
+21.4%
75,652
+6.6%
0.00%
Q2 2017$359,00070,9500.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,196,527$16,526,0003.00%
BVF INC/IL 5,328,239$27,547,0001.08%
Soleus Capital Management, L.P. 740,000$3,826,0000.60%
Cutter & CO Brokerage, Inc. 326,100$1,686,0000.40%
EAM Investors, LLC 288,459$1,491,0000.25%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$5,316,0000.15%
Rhenman & Partners Asset Management AB 300,000$1,551,0000.11%
Navis Wealth Advisors, LLC 16,000$83,0000.06%
Sigma Planning Corp 364,484$1,884,0000.06%
XTX Topco Ltd 32,650$169,0000.06%
View complete list of PIERIS PHARMACEUTICALS INC shareholders